当前位置: 首页 > FDA溶出度方法库 反馈纠错 帮助中心
-
药品名称 剂型 USP 溶出方法 转速(转/min) 溶出介质 容积 推荐采样时间 更新时间
Amphetamine Suspension (Extended Release)   Develop a dissolution method 2016-12-22
Mebendazole ( 500 mg) Tablet (Chewable) II (Paddle) 75 1% Sodium Lauryl Sulfate (SLS) in 0.01 N HCl 900 5, 10, 15, 30, 45 and 60 minutes 2016-12-22
Perampanel Suspension II (Paddle) 50 0.1 N HCl 900 [890 mL 0.1 N HC 5, 10, 15, 20 and 30 2016-12-22
Canagliflozin (Can)/ Metformin HCl (Met) Tablet (Extended Release)   Met: I (Basket, 40 mesh): Can: Met: 100: Can:100 Met: Simulated Gastric Fluid [SGF] without enzyme, pH 1.2; Can: 0.1% (w/v) polysorbate 20 in 0.05 M sodium phosphate buffer pH 6.8 ( 50 mg); 0.2% (w/v) polysorbate 20 in 0.05 M sodium phosphate buffer pH 6.8 (150 mg) Met: 900: Can: 900 Met: 1, 2, 4, 6, 8 10 and 12 hours: Can: 10, 15, 20, 30, 45 and 60 minutes; 2016-12-22
Oxycodone HCl/ Naloxone HCl Tablet (Extended Release)   II (Paddle) 50 Simulated Gastric Fluid [SGF, pH 1.2] without enzyme 900 0.25, 0.5, 1, 2, 4, 6, 8, 10 and 12 hours 2016-12-22
Naltrexone HCl / Oxycodone HCl Capsule (Extended Release)  Develop a dissolution method 2016-12-22
Simvastatin Suspension II (Paddle) 50 Phosphate Buffer, pH 7.0, with 0.14% sodium dodecyl sulfate (SDS) 900 10, 15, 20, 30 and 45 2016-12-22
Azithromycin Tablet  Refer to USP  2016-12-22
Atropine Sulfate/ Diphenoxylate HCl Tablet  Develop dissolution method(s) to characterize the dissolution of both components 2016-12-22
Granisetron Injectable (Extended Release) Develop a method to characterize in vitro release 2016-12-22
Aspirin/ Omeprazole Tablet (Delayed Release)  I (Basket) 100 Acid Stage: 0.1 N HCl (degassed); Buffer Stage: Phosphate Buffer, pH 6.8 (degassed) Acid Stage: 900; Buf Acid Stage:120; Buffer Stage:10, 20, 30, 45, 60 and 75 2016-12-22
Colchicine Capsule   II (Paddle) 75 Deionized Water with 2% Sodium Lauryl Sulfate (SLS) 500 5, 10, 15, 20 and 30 2016-12-22
Azithromycin Capsule Refer to USP  2016-12-22
Lorcaserin HCl Tablet  II (Paddle) 50 0.1 N HCl (deaerated) 900 5, 10, 15, 20 and 30  2016-12-22
Nitisinone Suspension II (Paddle) 50 pH 1.2 HCl Buffer (degassed) 1000 10, 15, 20, 30 and 45 2016-12-22
Dasabuvir Na/ Ombitasvir/Paritaprevir/Ritonavir Tablet (Extended Release)   III (Reciprocating Cylinder [4 25 dpm 15 mM hexadecyltrimethylammonium bromide (CTAB) in 0.03M Sodium Phosphate Buffer, pH 6.8 250 Ombitasvir/ Paritaprevir/ Ritonavir: 10, 15, 20, 30, 45, 60 and 90 minutes;Dasabuvir: 1, 2, 3, 6, 9, 2016-10-20
Carbidopa/Levodopa Suspension (Enteral) II (Paddle) 25 0.05 M Sodium Acetate Buffer, pH 4.5 500 5, 10, 15, 20, 30, 40 and 60 2016-10-20
Calcifediol Capsule (Extended Release)  II (Paddle) with sinker  75 0.5% SDS in 5 mM Sodium Dihydrogenphosphate Monohydrate, pH 6.8 500 1, 2, 4, 6, 8, 10 and 12 hours 2016-10-20
Empagliflozin/Metformin Hydrochloride Tablet II (Paddle) 50 Phosphate Buffer, pH 6.8 (deaerated) 900 5, 10, 15, 20 and 30 2016-10-20
Eltrombopag Olamine Suspension II (Paddle) 50 50 mM potassium phosphate in water, pH 6.8 with 0.2% polysorbate 80 750 4, 8, 12, 15 and 20 2016-10-20